From whole genome sequencing and custom gene panels for target discovery, to GLP/CLIA-level variant confirmation for FDA approval, GENEWIZ, a Brooks Life Sciences Company, has the genomic and sample management tools to support the development of your cell and gene therapies. A leading genomics services provider, GENEWIZ’s proprietary AAV-ITR Sanger sequencing, plasmid synthesis, and preparation capabilities support your AAV in vivo gene therapy research, enabling the treatment of a wide range of diseases. These groundbreaking AAV services also sequence-verify and correct inverted terminal repeat (ITR) regions, which is critical for rAAV packaging production.